APP and Alzheimer disease: This impairment is thought to be due to amyloid beta itself and the accumulation of the amyloid precursor protein-c terminal fragmentation (APP-CTF) in early AD models and human post-mortem sporadic AD brains that showcase clear morphological mitochondrial changes [63,64].